Biomedical engineers have successfully 3D printed human ligaments and tendons, giving hope to patients suffering from tears and ruptures.
After two years of intensive research, biomedical engineers have successfully 3D printed the complex structures of human ligaments and tendons.
Earlier this year, we hosted the Ending Age-Related Diseases 2018 conference at the Cooper Union in New York City. This conference was designed to bring together the best in the aging research and biotech investment worlds and saw a range of industry experts sharing their insights.
Dr. James Peyer is the founder and Managing Partner of Apollo Ventures, an early-stage life science investor and company builder that focuses on breakthrough technologies for treating age-related diseases.
He discusses the strategic paths to bringing longevity-promoting therapeutics to market as quickly as possible, with a particular focus on engaging pharmaceutical companies via disease-focused, proof-of-concept trials.
Earlier this year, we hosted the Ending Age-Related Diseases 2018 conference at the Cooper Union in New York City. This conference was designed to bring together the best in the aging research and biotech investment worlds and saw a range of industry experts sharing their insights.
Dr. Oliver Medvedik, LEAF vice president and Director of the Maurice Kanbar Center for Biomedical Engineering at the Cooper Union, chaired a panel with a focus on starting up biotech companies and dealing with the challenges inherent to launching a company in this industry.
It will be our second conference totally focussed on the science of actual human rejuvenation therapies to repair the damage of aging.
We are happy to begin introducing the speakers, starting with Dr. Jerry Shay.
Dr. Shay is the Vice Chairman of the Department of Cell Biology at The University of Texas Southwestern Medical Center in Dallas. Dr. Shay´s work on the relationships of telomeres and telomerase to aging and cancer is well recognized.
“Jerry has been a stalwart supporter of the SENS concept for well over a decade, and a world leader in the telomere biology field for much longer than that. He spoke at the very first SENS conference, back in 2003, and it will be a joy to welcome him again.” says Aubrey de Grey.
Exciting visitor at the Real Bodies (https://www.realbodies.it/) exhibit!
The lovely Ms. Chiara Bordi (https://www.facebook.com/Chiara-Bordi-474572166390000/), Miss Italia 3rd place runner up (aka the “Bionic Beauty”) stopping by to visit our associates at HealthQE (www.healthqe.cloud), and QantiQa (https://www.qantiqa.com/), to test out their new Musyke device
Bio-mechanics and Bio-acoustics
Two critical components in the regeneration, repair, and rejuvenation equation, and part of the integrated age-reversal paradigm of Embrykinesis at Bioquark Inc.- (www.bioquark.com)
Today is our first Ask LEAF Anything where you can ask us questions about our work in the rejuvenation biotechnology field.
In 2014, the Life Extension Advocacy Foundation was established as a 501©(3) non-profit organization dedicated to promoting healthy human lifespan through fiscally sponsoring longevity research projects and raising awareness regarding the societal benefits of healthy life extension.
Fletcher told the ABC the guidelines were developed in consultation with people living with autism, researchers and doctors, and had been approved by the National Health and Medical Research Council.
“It does not change what the NDIS does and indeed it may well be that there are people who, today, would not be diagnosed who will be diagnosed,” he said. “That will be a judgment for clinicians and medical profession and the NDIS will continue to do what it does, which is make an assessment of the impairment that somebody suffers as a result of a disability. Is it likely to be permanent and lifelong? Is it significant? What impact does it have on the functioning?”
Dr Wenn Lawson, the co-chair of the Australian Autism Research Council, said a consistent assessment and diagnosis process for autism meant people would be able to access more appropriate supports.